Mupicare
Brand Name: Mupicare
Generic Name: Mupirocin
Active
Registration Number
DRP-12991-02
Dosage Form
Topical Ointment
Issuance Date
May 31, 2023
Expiry Date
November 14, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength20mg/g (2% w/w)
Packaging5 g Aluminum Tube with HDPE cap (Box of 1's)
Classification
C
Classification
Over-the-Counter (OTC) Drug
A
Application
CLIDP Conversion
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
MupirocinActive
Monograph: Mupirocin